New selective PAD4 inhibitors binding a calcium-deficient form of the PAD4 enzyme have validated the essential enzymatic role of human and mouse PAD4 in equally histone citrullination and neutrophil extracellular entice development for, to our knowledge, the first time. The therapeutic likely of